Author Archives: John Geyman, M.D.

Cancer and Comparative Effectiveness Research

 > It is no longer unusual for chemotherapy to cost more than $100,000 a year. Oncologists are often reluctant to be “the bad guy” by denying patients the option of a treatment. Comparative effectiveness research may help determine which treatments are truly valuable, controlling costs and improving quality. read more »
| Print Print | Download as PDF | 4 Comments